4 studies found for:    ((sorafenib AND GIST) OR NCT00933777 OR NCT01128998) | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  SORAVE - Sorafenib and Everolimus in Solid Tumors
Condition: Relapsed and/or Refractory Solid Tumors
Intervention: Drug: Combination of sorafenib and everolimus
2 Unknown  Study on the Influence of Sunitinib and Sorafenib on Fatigue, QoL, Depression in Patients With Metastatic RCC or GIST
Conditions: Renal Cell Cancer;   Colorectal Cancer;   GIST
Intervention: Other: Questionnaires
3 Recruiting Caphosol in Oral Mucositis Due to Targeted Therapy
Conditions: Oral Mucositis;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Gastrointestinal Stromal Tumors
Interventions: Other: supersaturated calcium-phosphate rinse;   Other: sodium chloride 0.9 %
4 Recruiting A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo

Indicates status has not been verified in more than two years